Atea Pharmaceuticals (AVIR) Receivables - Other (2020)
Historic Receivables - Other for Atea Pharmaceuticals (AVIR) over the last 1 years, with Q4 2020 value amounting to $5.8 million.
- Atea Pharmaceuticals' Receivables - Other changed N/A to $5.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was $5.8 million, marking a year-over-year change of. This contributed to the annual value of $5.8 million for FY2020, which is N/A changed from last year.
- Per Atea Pharmaceuticals' latest filing, its Receivables - Other stood at $5.8 million for Q4 2020.
- Atea Pharmaceuticals' Receivables - Other's 5-year high stood at $5.8 million during Q4 2020, with a 5-year trough of $5.8 million in Q4 2020.